AW
JBIO icon

Avion Wealth’s Jade Biosciences JBIO Stock Holding History

Avion Wealth’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-7
Closed – – 1419
2026
Q2 		$0 Hold
7
– – ﹤0.01% 1434
2026
Q1 		$0 Hold
7
– – ﹤0.01% 1239
2025
Q4 		$0 Hold
7
– – ﹤0.01% 1227
2025
Q3 		$0 Hold
7
– – ﹤0.01% 1195
2025
Q2 		$0 Hold
7
– – ﹤0.01% 1156
2025
Q1 		$0 Buy
+7
New +$615 ﹤0.01% 1014
2024
Q4 		– Sell
-7
Closed – – 1001
2024
Q3 		$0 Buy
+7
New +$452 ﹤0.01% 994

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Avion Wealth's JBIO Position: Q3 2026 in Review

Avion Wealth sold out of Jade Biosciences (JBIO) in Q3 2026, closing a stake of 7 shares.

Avion Wealth first reported a position in JBIO in Q3 2024 and held it in 7 quarters. The position peaked at $0 in Q2 2026. 53 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • Avion Wealth reported no remaining Jade Biosciences position as of Q3 2026 after selling out during the quarter.
  • Avion Wealth sold 7 Jade Biosciences shares in Q3 2026.
  • Avion Wealth first reported a position in Jade Biosciences in Q3 2024 and held it in 7 quarters.
  • Avion Wealth's Jade Biosciences position peaked at $0 in Q2 2026.
  • 53 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.